Vaccines against Influenza A (H5N1): Evidence of Progress | Zendy

Gregory A. Poland | Zendy; Suryaprakash Sambhara | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vaccines against Influenza A (H5N1): Evidence of Progress

Author(s) -

Gregory A. Poland,

Suryaprakash Sambhara

Publication year - 2008

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/590912

Subject(s) - pandemic , influenza a virus subtype h5n1 , influenza pandemic , clarity , transmission (telecommunications) , virology , human mortality from h5n1 , medicine , immunology , covid-19 , virus , biology , infectious disease (medical specialty) , disease , biochemistry , pathology , electrical engineering , engineering

tries, with a mortality rate of >60% [1]. Should this virus mutate such that upper airway infection of humans occurs, allowing human-to-human transmission, an influenza pandemic would result. The consequences of such a pandemic cannot be predicted with clarity; nonetheless, it will result in excess morbidity and mortality and, if severe enough, widespread global social and economic disruption [2]. Of note is that Japan recently announced plans to immunize health care workers and other essential personnel

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research